• Home
  • Grand Canyon University
  • Health Policy and Economic Analysis Care HCA-255
  • Health Policy and Pharmaceutical Industry

Health Policy and Pharmaceutical Industry

Name: Kylie McNiven Course: HCA-255-0500 Date: 10/19/2020 Instructor: Barri Seif The Pharmaceutical Industry The use of medicine or drugs dates back as far as the Medieval Ages there are records of earlier people that used herbs and other plants for their healing properties. Some of these plants did have recognized healing properties and are still used today. The pharmaceutical industry does play a major role with developing medications and vaccines to reduce the occurrence of diseases, treat diseases, and increase the quality of life for people. The main advancements are through research is to keep up with the complex healthcare demands of population growth. The industry does influence the process of defining illness, increase the public awareness of disease and develop effective therapies for painful conditions this influence can be positive. The influence in the industry can become harmful if it is on boundary of illness too far for profit, if their sales representatives downplays the seriousness of the side effects, encourages off-label prescribing that is not supported by evidence or by the FDA approval, concerns have been raise about how all these practices could influence prescribers and patients to end up preferring off brand-name drugs even when they do not compare to other alternatives in terms of costs, effectiveness, or risks. The United States does dominate the pharmaceutical market and pharmaceutical trends compared to other countries, both in development and consumption, there have been concerns about drug overcharging for generic drugs and this is influencing international markets in order to establish firm price control on new medicine that is developed. Most governments do force regulations on pharmaceutical companies, in order protect the public from damaging drug effects. These rules often extend the process for bringing new pharmaceuticals into the market. The Food and Drug Administration (FDA) makes certain that new drugs are diligently tested for safety and effectiveness, with minimizing side effects on the patients. The government does mandate the drug sector pretty will and it has resulted in longer, more-expensive product processes that do benefit treatments for rare the illnesses that are out there. All approved drugs have been meticulous tested by the The Food and Drug Administration in an ongoing effort to protect consumers from harmful or unsuccessful treatments and overdoses (Gauvin, Zimmermann, & Kallman, 2016). The Adverse Drug Event Prevention (ADE) was created to address two objectives which are identify common, preventable, and measurable adverse drug events that may result in remarkable harm of the patient; and to line up the efforts of Federal health agencies to reduce patient harms from bleeding, hypoglycemia), and accidental overdoses, over sedation, and depression. An adverse drug event is an injury resulting from medical intervention related to a drug. This broad term encompasses harms that occur during medical care that are directly caused by the drug including but are not limited to medication errors, adverse drug reactions, allergic reactions, and overdoses (Aspden, et al., 2004). Medication errors can be described as inappropriate use of a drug that may or may